Author: Ulrich, Henning; Pillat, Micheli M.; Tárnok, Attila
Title: Dengue Fever, COVIDâ€19 (SARSâ€CoVâ€2), and Antibodyâ€Dependent Enhancement (ADE): A Perspective Cord-id: 35ktwpwz Document date: 2020_6_7
ID: 35ktwpwz
Snippet: SARSâ€CoVâ€2 pandemic and recurrent dengue epidemics in tropical countries have turned into a global health threat. While both virusâ€caused infections may only reveal light symptoms, they can also cause severe diseases. Here, we review the possible antibodyâ€dependent enhancement (ADE) occurrence, known for dengue infections, when there is a second infection with a different virus strain. Consequently, preexisting antibodies do not neutralize infection, but enhance it, possibly by triggerin
Document: SARSâ€CoVâ€2 pandemic and recurrent dengue epidemics in tropical countries have turned into a global health threat. While both virusâ€caused infections may only reveal light symptoms, they can also cause severe diseases. Here, we review the possible antibodyâ€dependent enhancement (ADE) occurrence, known for dengue infections, when there is a second infection with a different virus strain. Consequently, preexisting antibodies do not neutralize infection, but enhance it, possibly by triggering Fcγ receptorâ€mediated virus uptake. No clinical data exist indicating such mechanism for SARSâ€CoVâ€2, but previous coronavirus infections or infection of SARSâ€CoVâ€2 convalescent with different SARSâ€CoVâ€2 strains could promote ADE, as experimentally shown for antibodies against the MERSâ€CoV or SARSâ€CoV spike S protein. © 2020 International Society for Advancement of Cytometry
Search related documents:
Co phrase search for related documents- abdominal pain and ade antibody dependent enhancement: 1
- active vaccination and adaptive immunity: 1
Co phrase search for related documents, hyperlinks ordered by date